Mojo Night Supplements Recalled for Unapproved Drug Ingredient

Mojo Night Supplements are being recalled for an unapproved drug ingredient, the U.S. Food & Drug Administration (FDA) just announced.

Evol Nutrition Associates, Inc./Red Dawn of Kennesaw, Georgia said it is conducting a nationwide recall of all lots of two dietary supplement products it distributes under the names Mojo Nights and Mojo Nights for Her. Both supplements are manufactured by, and are products of, Mojo Health of Lauderhill, Florida.

FDA testing revealed the presence of undeclared tadalafil and sildenafil in Mojo Nights; Mojo Nights for Her is being recalled as a precautionary measure.

Tadalafil and sildenafil are active ingredients of FDA-approved drugs for Erectile Dysfunction (ED). Their presence in the supplement makes Mojo Nights an unapproved new drug. Also, the undeclared active ingredients may interact with nitrates, which are found in some prescription drugs, such as nitroglycerin, and may lower blood pressure to dangerous levels. Of note, consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.

To date, no illnesses have been reported to the company in connection with these products and this recall.

Mojo Mights and Mojo Nights for Her were distributed, nationwide, via retail stores and Internet sales, from July 2011 to  July 2012. All lots of the following one-capsule packages of Mojo Nights and Mojo Nights for Her are involved in the recall:

  • Mojo Nights: UPC 7 18122 11983 7
  • Mojo Nights for Her: UPC 7 18122 12133 5

Evol Nutrition is notifying its customers by certified mail and advises customers in possession of the recalled Mojo Nights supplements to stop using the products immediately and destroy the product or return it for a refund. Evol Nutrition may be reached, toll-free, at 1.866.639.3865, Monday through Friday, from 9:00 a.m. and 5:00 p.m., Eastern Standard Time (EST).

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program online, by regular mail,, by fax or online; by regular mail or fax, use postage-paid, pre-addressed Form FDA 3500 available here and either mail to address on the pre-addressed form or fax to 1.800.FDA.0178.

This entry was posted in Pharmaceuticals and tagged . Bookmark the permalink.

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.